1. bookVolume 28 (2020): Issue 1 (January 2020)
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

HBV genotypes circulation in pregnant women in Romania: a pilot study

Published Online: 07 Feb 2020
Volume & Issue: Volume 28 (2020) - Issue 1 (January 2020)
Page range: 91 - 98
Received: 11 Oct 2019
Accepted: 12 Jan 2020
Journal Details
License
Format
Journal
eISSN
2284-5623
First Published
08 Aug 2013
Publication timeframe
4 times per year
Languages
English
Abstract

Background: The risk of mother to child transmission of hepatitis B virus (HBV) is recognized worldwide, a reason for which the World Health Organization aims to reduce this public health issue of major concern in the next ten years. The aim of our study was to detect circulating HBV genotypes in a selected population of pregnant women, as scientific evidence to recommend personalized antiviral therapy and to obtain updated epidemiological information.

Methods: HBsAg positive pregnant women were selected by the National Institute of Public Health Romania. Blood samples were collected after signing the informed consent. The HBV genotypes were tested by INNO LiPA HBV genotyping method.

Results. The D genotype was detected in 9/18 (50%) patients, genotype A in 3/18 (16.7%), and genotype F in 3/18 (16.7%) patients. Three patients had double infection, 11 had unique infection, and 4 had no detectable genotype.

Conclusion. This study confirmed the results of previous studies regarding HBV genotype circulation in our country, with the mention that F genotype was a new one for our area. These data are useful from an epidemiological point of view and also for therapeutical reasons, as it is known that therapy should be genotype guided.

Keywords

1. WHO Regional Committee for Europe, Action plan for the health sector response to viral hepatitis in the WHO European Region, WHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark, 2017, viii + 44 pages.Search in Google Scholar

2. IARC Working Group, HEPATITIS B VIRUS, International Agency for Research on Cancer, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 150 cours Albert Thomas, 69372 Lyon Cedex 08, France, 2012;100(Pt B):1-441.Search in Google Scholar

3. Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370-98. DOI: 10.1016/j.jhep.2017.03.02110.1016/j.jhep.2017.03.02128427875Search in Google Scholar

4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. DOI: 10.3322/caac.2149210.3322/caac.2149230207593Search in Google Scholar

5. Popovici O, Radu R, Romaniuc A, Azoicăi D. A sero-prevalence study for hepatitis B virus markers of infection in pregnant women in Romania: results and opportunities for prevention. J Gastrointestin Liver Dis. 2018 Jun;27(2):133-7. DOI: 10.15403/jgld.2014.1121.272. hpb10.15403/jgld.2014.1121.272Search in Google Scholar

6. Popovici O, Molnar GB, Popovici F, Janţă D, Pistol A, Azoicăi D. A Seroprevalence Study of Hepatitis B and C Virus Infections in a Hospitalized Population in Romania, an Opportunity for a Better National Prevention and Control Strategy. J Gastrointestin Liver Dis. 2016 Mar;25(1):25-32. DOI: 10.15403/jgld.2014.1121.251. hbc10.15403/jgld.2014.1121.251Search in Google Scholar

7. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):33-4. DOI: 10.1002/cld.72810.1002/cld.728638589930988907Search in Google Scholar

8. Ursu RG, Luca CM, Luca AS, Toader E, Simion L, Iancu LS. Laboratory diagnosis for optimize therapy of B hepatitis virus infection by using biochemical and molecular biology methods. Rev. Chim. (Bucharest), 2016; 67(12): 2614-261.Search in Google Scholar

9. Luca AS, Luca MC, Ursu RG, Iancu LS. The Study of VHB genotypes in a population - a pilot study. Rev. Chim. (Bucharest), 2016; 67(3): 500-2.Search in Google Scholar

10. Constantinescu I, Nedelcu F, Toader MA, Daniela V. Clinical and therapeutical importance of HBV genotyping in Romania. J Med Life. 2008 Apr-Jun;1(2):165-73.Search in Google Scholar

11. Constantinescu I, Dinu AA, Boscaiu V, Niculescu M. Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, Romania. Hepat Mon. 2014 Oct 20;14(10):e22072. DOI: 10.5812/hepatmon.2207210.5812/hepatmon.22072425096625477976Search in Google Scholar

12. Kmet Lunaček N, Poljak M, Matičič M. Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review. Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):141-6. DOI: 10.15570/actaapa.2018.2810.15570/actaapa.2018.28Search in Google Scholar

13. Toy M, Veldhuijzen IK, Mostert MC, de Man RA, Richardus JH. Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands. J Med Virol. 2008 Mar;80(3):399-404. DOI: 10.1002/jmv.2109810.1002/jmv.2109818205235Search in Google Scholar

14. Moussa S, Brah S, Parola P, Gerolami R, Gamerre M, Boubli L, et al. Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France. J Med Virol. 2016 May;88(5):828-36. DOI: 10.1002/jmv.2439810.1002/jmv.2439826439319Search in Google Scholar

15. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan;13(1):183-92.Search in Google Scholar

16. Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):249-55. DOI: 10.1016/j.bpg.2017.04.01010.1016/j.bpg.2017.04.01028774406Search in Google Scholar

17. Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol. 2014 Jun 21;20(23):7152-68. DOI: 10.3748/wjg.v20.i23.715210.3748/wjg.v20.i23.7152406406124966586Search in Google Scholar

18. Rajoriya N, Combet C, Zoulim F, Janssen HLA. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? J Hepatol. 2017 Dec;67(6):1281-97. DOI: 10.1016/j.jhep.2017.07.01110.1016/j.jhep.2017.07.01128736138Search in Google Scholar

19. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014 May 14;20(18):5427-34. DOI: 10.3748/wjg.v20. i18.5427Search in Google Scholar

20. Velkov S, Ott JJ, Protzer U, Michler T. The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes (Basel). 2018 Oct 15;9(10). DOI: 10.3390/genes910049510.3390/genes9100495621029130326600Search in Google Scholar

21. Lampe E, Mello FCA, do Espírito-Santo MP, Oliveira CMC, Bertolini DA, Gonçales NSL, et al. Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study. J Gen Virol. 2017 Jun;98(6):1389-98. DOI: 10.1099/jgv.0.00078910.1099/jgv.0.000789596289628631602Search in Google Scholar

22. Marciano S, Galdame OA, Gadano AC. HBV genotype F: natural history and treatment. Antivir Ther. 2013;18(3 Pt B):485-8. DOI: 10.3851/IMP260410.3851/IMP260423792712Search in Google Scholar

23. Hirzel C, Wandeler G, Owczarek M, Gorgievski-Hrisoho M, Dufour JF, Semmo N, et al. Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study. BMC Infect Dis. 2015 Oct 30;15:483. DOI: 10.1186/s12879-015-1234-z10.1186/s12879-015-1234-z462834426518625Search in Google Scholar

24. Michitaka K, Hiraoka A, Imai Y, Utsunomiya H, Tatsukawa H, Shimizu Y, et al. Clinical features and hepatitis B virus (HBV) genotypes in pregnant women chronically infected with HBV. Intern Med. 2012;51(24):3317-22. DOI: 10.2169/internalmedicine.51.859610.2169/internalmedicine.51.859623257514Search in Google Scholar

25. Ding Y, Sheng Q, Ma L, Dou X. Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J. 2013 Jan 7;10:17. DOI: 10.1186/1743-422X-10-1710.1186/1743-422X-10-17356801123294983Search in Google Scholar

26. Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark. Vaccine. 2011 Nov 21;29(50):9303-7. DOI: 10.1016/j.vaccine.2011.10.02810.1016/j.vaccine.2011.10.02822019756Search in Google Scholar

27. Dervisevic S, Ijaz S, Chaudry S, Tedder RS. Non-A hepatitis B virus genotypes in antenatal clinics, United Kingdom. Emerg Infect Dis. 2007 Nov;13(11):1689-93. DOI: 10.3201/eid1311.07057810.3201/eid1311.070578337577818217552Search in Google Scholar

28. Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, et al. Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns. Liver Int. 2015 Feb;35(2):409-16. DOI: 10.1111/liv.1256110.1111/liv.1256124698736Search in Google Scholar

29. Faleye TO, Adewumi MO, Ifeorah IM, Omoruyi EC, Bakarey SA, Akere A, et al. Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria. Springerplus. 2015 Feb 1;4:43. DOI: 10.1186/s40064-015-0813-110.1186/s40064-015-0813-1432014125674500Search in Google Scholar

30. Baclig MO, Reyes KG, Liles VR, Gopez-Cervantes J. Untypable genotype restriction patterns and surface gene variants of hepatitis B virus isolates. Int J Mol Epidemiol Genet. 2017 Jun 20;8(3):19-26.Search in Google Scholar

31. Pettersson JH, Myking S, Elshaug H, Bygdås KIE, Stene-Johansen K. Molecular epidemiology of hepatitis B virus infection in Norway. BMC Infect Dis. 2019 Mar 7;19(1):236. DOI: 10.1186/s12879-019-3868-810.1186/s12879-019-3868-8640726730845915Search in Google Scholar

32. Alidjinou EK, Bocket L, Pigot V, Lambert V, Hallaert C, Canva V, et al. Sanger sequencing versus INNO-Li-PA® HBV PreCore assay for routine detection of pre-core and basal core promoter mutations in hepatitis virus B chronically infected patients. Diagn Microbiol Infect Dis. 2018 Apr;90(4):277-279. DOI: 10.1016/j.diagmicrobio.2017.12.00610.1016/j.diagmicrobio.2017.12.00629310947Search in Google Scholar

33. Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW et al. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology. 2014 Apr;146(4):980-8. DOI: 10.1053/j.gastro.2013.12.02810.1053/j.gastro.2013.12.02824368224Search in Google Scholar

34. Chevaliez S, Dauvillier C, Dubernet F, Poveda JD, Laperche S, Hézode C, et al. The New Aptima HBV Quant Real-Time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F. J Clin Microbiol. 2017 Apr;55(4):1211-9. DOI: 10.1128/JCM.02219-1610.1128/JCM.02219-16537784928202793Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo